Award
NIH Reporter #5R01EY030766-06
Anti-ceramide immunotherapy for diabetic retinopathy
Recipient
University of Oklahoma Health Sciences Center
Award Amount
$401,386.00
Ceiling
$401,386.00
Awarded
May 13, 2026
Identifier
5R01EY030766-06
The award supports research on anti-ceramide immunotherapy to prevent or treat diabetic retinopathy by inhibiting ceramide signaling and restoring vascular repair.
Description
This project aims to develop and test anti-ceramide immunotherapy to prevent or treat diabetic retinopathy by targeting ceramide signaling pathways and restoring vascular repair mechanisms.